BDX vs MYX

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

BDX

BCAL FPO [BDX]

46LOW

MYX

M PHARMA FPO [MYX]

46LOW

Score Breakdown

BDX MYX
Technical
66
65
Catalyst
53
86
Sentiment
50
50
Fundamental
34
87
Momentum
75
33
Risk Gate
50
45

Key Metrics

BDX Metric MYX
$35.0MMarket Cap$187.7M
217KAvg Volume (20d)596K
N/AShort Interest+2.1%
$0.15552-Week High$7.295
$0.05252-Week Low$2.040
+5.3%Daily Change-0.9%
$0.100Entry Price$2.300
-121.7%ROE-20.6%
-282.1%Profit Margin-20.4%

Active Signals

BDX Signals

●RSI drifting toward oversold territory — worth watching
●Trading above the 200-day average — the long-term trend is on your side
●Low cash runway (2 quarters) - dilution risk
●Moderate P/S ratio (13.8x)
●Revenue declining (-8%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)
●Capital raise activity (1 events)

MYX Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Volume surging at 2.4x normal while price falls — heavy selling pressure
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.5x)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare BDX and MYX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
BDX Full Analysis → MYX Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).